Lumeon raises $30M to fuel growth in the US - Gilde Healthcare

Lumeon raises $30M to fuel growth in the US

August 11, 2020

Boston (Massachusetts, US) and Utrecht (The Netherlands) – Lumeon, the leader in care pathway orchestration, today announced that it has closed $30M in Series D funding led by new investors Optum Ventures and Endeavour Vision, with participation from current investors Gilde Healthcare, MTIP, IPF Partners, LSP and Amadeus Capital Partners. The investment will enable the company to extend the reach of its Care Pathway Management (CPM) platform, which helps healthcare providers automate their patient care coordination to improve care quality, deliver better outcomes and reduce costs.

Lumeon’s CPM platform uses real-time data to dynamically guide patients and care teams along their care journeys. By automating, orchestrating and virtualizing care delivery across care settings, Lumeon’s solutions allow health systems to operate with predictability and efficiency, delivering optimal care to each patient while substantially lowering costs for healthcare providers.

“As the technology-driven transformation of healthcare is accelerated by COVID-19, Lumeon’s ability to optimize the care of every patient based on individual risk, cost, engagement and social determinants is crucial for their customers to operate effectively,” said Optum Ventures Principal Dr. Ashish Patel. “We believe Lumeon is uniquely positioned to help health systems unlock new opportunities in sustainable, profitable care delivery.”

Lumeon’s CPM platform integrates with all electronic health record (EHR) systems in addition to incorporating required clinical and administrative data from point solutions and devices, addressing the fragmented nature of healthcare technology and the challenge of interoperability. By extending beyond the confines of a healthcare provider’s EHR, Lumeon’s configurable solutions maximize current investments as organizations evolve their care delivery models.

 

About Lumeon

Lumeon helps health systems take control of their care delivery processes by orchestrating and automating care journeys to operate with predictability and efficiency. Its industry-leading solutions act as the ‘auto-pilot’ for healthcare delivery, navigating the patient care journey while coordinating care teams, communication, tasks, and decisions to increase revenue, optimize resource utilization, and deliver superior outcomes at less cost. Lumeon’s solutions are enabled by their cloud-based care pathway management (CPM) platform. Capitalizing on the patient’s electronic health record (EHR), health systems can start simply with immediate benefits and evolve to orchestrate their entire care process. More than 70 progressive health systems across 12 countries have deployed Lumeon’s multi-award-winning platform. For more information, visit the company’s website at www.lumeon.com.

About Optum Ventures

Optum Ventures is the independent venture fund of Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone, and part of UnitedHealth Group. Optum Ventures invests in digital health companies that use data and insights to help improve consumers’ access to health care services and how care is delivered and paid for, and that make the health care system more reliable and easier to navigate. For more information, visit the company’s website at www.optumventures.com.

About Gilde Healthcare

Gilde Healthcare is a specialized European healthcare investor managing €1.4 billion ($1.5 billion) across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market. For more information, visit the company’s website at www.gildehealthcare.com.

For further information, contact:

Hanah Johnson
March Communications
lumeon@marchcomms.com
+1 617-960-8892

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Koscher & Würtz

The acquisition of Koscher & Würtz represents a major step for Gilde Healthcare in forming a market leading instrument contract manufacturing group, following its initial investment in Chr. Diener, less than 18 months ago. Koscher...
November 20, 2023

Gilde Healthcare closes new Venture&Growth fund at €740 million hard cap

Gilde Healthcare Venture&Growth VI closes at its hard cap with €740 million from a balanced mix of international investors Gilde Healthcare invests in fast growing companies that enable better care at lower cost, supported by...
November 15, 2023

Gilde Healthcare company SpliceBio enters $216 million Gene Therapy collaboration with Spark Therapeutics

SpliceBio is eligible to receive upfront, opt-in and milestone payments up to $216 million plus royalties Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture, and commercialize a gene therapy...
October 17, 2023